Kaveri Suryanarayan
- Hematology top 5%
- Multiple Myeloma Research and Treatments 21
- Chronic Myeloid Leukemia Treatments 4
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 7
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
-
- Lymphoma Diagnosis and Treatment 3
-
- Cancer Treatment and Pharmacology 4
-
- Acute Lymphoblastic Leukemia research 6
-
- Protein Degradation and Inhibitors 8
- Co-authors
- C A WestbrookDouglas TkachukJoe W. GrayD. PinkelMichael L. ClearyArlene RednerMichael AndreeffML Cleary
- Partner nations
- United StatesGreeceSpain
In The Last Decade
Kaveri Suryanarayan
30 papers receiving 632 citations
Peers
Comparison fields: 5 of 68
- Hematology 334
- Genetics 144
- Pathology and Forensic Medicine 109
- Oncology 158
- Public Health, Environmental and Occupational Health 139
Countries citing papers authored by Kaveri Suryanarayan
This map shows the geographic impact of Kaveri Suryanarayan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaveri Suryanarayan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaveri Suryanarayan more than expected).
Fields of papers citing papers by Kaveri Suryanarayan
This network shows the impact of papers produced by Kaveri Suryanarayan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaveri Suryanarayan. The network helps show where Kaveri Suryanarayan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kaveri Suryanarayan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 25 | |
| 5 | 2022 | 0 | |
| 6 | 2022 | 7 | |
| 7 | 2021 | 2 | |
| 8 | 2021 | 12 | |
| 9 | 2020 | 17 | |
| 10 | 2020 | 6 | |
| 11 | 2020 | 13 | |
| 12 | 2019 | 1 | |
| 13 | 2017 | 14 | |
| 14 | 2015 | 32 | |
| 15 | 2002 | 18 | |
| 16 | 2002 | 5 | |
| 17 | 2001 | 15 | |
| 18 | 1998 | 5 | |
| 19 | 1998 | 14 | |
| 20 | 1991 | 4 |
About Kaveri Suryanarayan
Kaveri Suryanarayan is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Oncology and Pathology and Forensic Medicine, having authored 33 papers that have together received 651 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (21 papers), Protein Degradation and Inhibitors (8 papers), Chronic Lymphocytic Leukemia Research (7 papers), Acute Lymphoblastic Leukemia research (6 papers), Cancer Treatment and Pharmacology (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Hematology (334 citations), Genetics (144 citations), Pathology and Forensic Medicine (109 citations), Oncology (158 citations) and Public Health, Environmental and Occupational Health (139 citations). Kaveri Suryanarayan has collaborated with scholars based in United States, Greece and Spain. Frequent co-authors include C A Westbrook, Douglas Tkachuk, Joe W. Gray, D. Pinkel, Michael L. Cleary, Arlene Redner, Michael Andreeff, ML Cleary, Sabine Köhler and SP Hunger. Their work appears in journals such as Blood, HemaSphere, Journal of Pediatric Hematology/Oncology, Journal of Clinical Oncology and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.